Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience
The Bavarian tool implemented uses the prescribing volume (DDD) and price components to evaluate the prescription behaviour of physicians. Well-established drugs with demonstrated effectiveness, safety, and lower costs are preferred. Nevertheless, me-too drugs, combination drugs, costly innovations with unclear value, and drugs with application methods of variable convenience challenge the drug prescribers and are reasons for missed drug targets.
Authors
- Norbert Donner‐Banzhoff (ORCID: https://orcid.org/0000-0002-8688-1835)
- Maria Sebastião (ORCID: https://orcid.org/0000-0002-0838-7989)
- Peter Killian
- Franziska Hörbrand
- Julia Gollnick (ORCID: https://orcid.org/0009-0001-2804-5660)
- Julia Muth
- Thomas Kühlein
- Kerstin Behnke
- Nikoletta Zeschick
Institutions
- Philipps University of Marburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- National Association of Statutory Health Insurance Physicians (DE)
Publication Details
- Journal
- International Journal of Environmental Research and Public Health
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3390/ijerph21091174
- Citations
- 3
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.39
Funders
- Gemeinsame Bundesausschuss